Article Versions Notes

Cabioglu N, Onder S, Karatay H, Bayram A, Oner G, Tukenmez M, Muslumanoglu M, Igci A, Dinccag A, Ozmen V, et al. New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer. Cancers. 2024; 16(13):2388. https://doi.org/10.3390/cancers16132388

Cabioglu, Neslihan, Semen Onder, Hüseyin Karatay, Aysel Bayram, Gizem Oner, Mustafa Tukenmez, Mahmut Muslumanoglu, Abdullah Igci, Ahmet Dinccag, Vahit Ozmen, and et al. 2024. "New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer" Cancers 16, no. 13: 2388. https://doi.org/10.3390/cancers16132388

Cabioglu, N., Onder, S., Karatay, H., Bayram, A., Oner, G., Tukenmez, M., Muslumanoglu, M., Igci, A., Dinccag, A., Ozmen, V., Aydiner, A., Saip, P., & Yavuz, E. (2024). New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer. Cancers, 16(13), 2388. https://doi.org/10.3390/cancers16132388